Journal profile · Oncology
Cancer
ISSN 0008-543X · eISSN 1097-0142 · John Wiley and Sons Inc. · UNITED STATES · Semimonthly
Cancer: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 5.6; hybrid open access; APC about USD 4,790; median 98 days to acceptance (80 articles, last 24 months); community-reported acceptance: fairly easy; 567 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Cancer is published by John Wiley and Sons Inc. and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Lymphoma Diagnosis and Treatment, Breast Cancer Treatment Studies and Global Cancer Incidence and Screening, together about 20.3% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Cancer seeks to impart highly relevant and timely information to a broad audience of oncology and related specialists in the field. Cancer accomplishes this objective by publishing original and review articles that facilitate the transfer of knowledge from the laboratory to the bedside; contribute to cancer prevention, early detection, diagnosis, cure, and rehabilitation; and diminish suffering from cancer. Cancer also publishes educational supplements on various topics that are of interest to a broad oncology audience..
From the journal's Aims & Scope
Research area (LetPub): Oncology
Editor-in-chief Fadlo R. KhuriPublisher website
Editorial board by country: none in mainland China; most named Canada 1, Australia 1, Lebanon 1 (3 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Lymphoma Diagnosis and TreatmentMedicine7.2%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology6.8%
- Global Cancer Incidence and ScreeningMedicine6.4%
- Sarcoma Diagnosis and TreatmentMedicine6.3%
- Head and Neck Cancer StudiesMedicine4.4%
- Lung Cancer Treatments and MutationsMedicine4.2%
- Acute Lymphoblastic Leukemia researchMedicine4.1%
- Cancer survivorship and careMedicine4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Oncology | Zone 2 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 2 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedEmbaseCASCAB AbstractsCINAHLCurrent ContentsPublisher website
Other: EBSCO
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.6LetPub ·
- Impact factor (publisher) 2025
- 5.6Publisher website ·
- CiteScore 2026-06
- 10.6LetPub ·
- CiteScore (publisher) 2025
- 10.6Publisher website ·
- SJR 2026-06
- 2.43LetPub ·
- SNIP 2026-06
- 1.96LetPub ·
- h-index
- 277LetPub ·
- h-index
- 474OpenAlex ·
- i10-index
- 38,013OpenAlex ·
- 2-year mean citedness
- 4.49OpenAlex ·
- Self-citation rate
- 1.8%LetPub ·
- Share of gold OA articles
- 40.3%LetPub ·
Volume
- Articles per year
- 327LetPub ·
- Articles per year (publisher) 2025
- 410Publisher website ·
- Downloads per year (publisher) 2025
- 6,458,814Publisher website ·
Articles by year OpenAlex count · 53,065 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 401 | 245 | 192 |
| 2025 | 567 | 396 | 1,839 |
| 2024 | 549 | 422 | 4,780 |
| 2023 | 598 | 521 | 6,759 |
| 2022 | 582 | 285 | 9,603 |
| 2021 | 731 | 557 | 17,870 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
98 daysMedian, submission to acceptance · P25–P75 74 days – 139 days
- Acceptance to online
- median 38 days (80 articles)
- Submission to online
- median 146 days
- Sample
- 80 articles with submission and acceptance dates (1,033 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 2–3 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Acceptance rate (publisher) 2025
- 8%Publisher website ·
- Submission to first decision 2025
- 1 daysPublisher website ·
- Submission to acceptance 2025
- 89 daysPublisher website ·
- Acceptance to publication 2025
- 35 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,790 / EUR 4,110 / GBP 3,430 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
Other charges and waivers (author guidelines)
- Submission fee
- No submission fee
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- ≤ 250 words
- Reference style
- AMA
- First submission
- Free format: the journal's layout is not required
- Not considered
- case reports
Article types accepted13, with length limits
- cancer case conundrumsCancer Case Conundrums Presents unusual cases and questions without an obvious solution 1000 limit No Must be invitedmain text ≤ 1,000 words
- case reportArticle Type Description Word Limit Abstract / Structure Other Requirements Original Article Scientific report of the results of original clinical research 3500…Length not stated
- clinical practice guidelineClinical Practice Guideline Public statement from an organization or representative group of experts that includes evidence-based recommendations to optimize pa…Length not stated
- commentaryArticle Type Description Word Limit Abstract / Structure Other Requirements Original Article Scientific report of the results of original clinical research 3500…main text ≤ 4,000 words
- consensus statementConsensus Statement Public statement from a representative group of experts that provides guidance on an issue for the purpose of advancing understanding and im…Length not stated
- editorialArticle Type Description Word Limit Abstract / Structure Other Requirements Original Article Scientific report of the results of original clinical research 3500…main text ≤ 1,500 words
- insight from the expertsInsight From the Experts Offers research, approaches, and perspectives that provide our readers with honest, earned wisdom and guidance from established experts…main text ≤ 1,000 words
- letter to the editorArticle Type Description Word Limit Abstract / Structure Other Requirements Original Article Scientific report of the results of original clinical research 3500…main text ≤ 750 words
- opinionArticle Type Description Word Limit Abstract / Structure Other Requirements Original Article Scientific report of the results of original clinical research 3500…Length not stated
- original articleArticle Type Description Word Limit Abstract / Structure Other Requirements Original Article Scientific report of the results of original clinical research 3500…main text ≤ 3,500 words
- perspectiveArticle Type Description Word Limit Abstract / Structure Other Requirements Original Article Scientific report of the results of original clinical research 3500…Length not stated
- position statementPosition Statement Public statement from an organization on a position relevant to clinical practice, health policy, or social concerns Yes, unstructuredLength not stated
- review articleArticle Type Description Word Limit Abstract / Structure Other Requirements Original Article Scientific report of the results of original clinical research 3500…main text ≤ 4,000 words
Policy excerpts from the journal's websiteAI use, Authorship, Data availability, License & copyright, Open access, Peer review, Preprints, Self-archiving
- AI use Disclosing the use of artificial intelligence (AI)
If you or your co-authors have used Artificial Intelligence Generated Content (AIGC) tools such as ChatGPT and others based on large language models (LLMs) to develop any portion of a manuscript, their use must be described transparently and in detail in the Methods section.
Source ↗Publisher website ·- Authorship Authorship
All listed authors should have contributed to the manuscript substantially and have agreed to the final submitted version. Review editorial standards and scroll down for a description of authorship criteria.
Source ↗Publisher website ·- Data availability Data Sharing and Data Availability
This journal expects data sharing. Review Wiley’s Data Sharing policy where you will be able to see and select the data availability statement that is right for your submission.
Source ↗Publisher website ·- License & copyright Reproduction of Copyright Material
If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is your responsibility to also obtain written permission for reproduction from the copyright owners. For more information visit Wiley’s Copyright Terms & Conditions FAQ.
Source ↗Publisher website ·- Open access Open Access
No submission fees Model summary
This journal is a subscription journal that offers an Open Access option. You’ll have the option to make your article open access after acceptance, which will be subject to an APC unless a waiver applies. Read more about APCs here.
Source ↗Publisher website ·- Peer review 1. Submission and Peer Review Process
Single-anonymized peer review model Model summary
New submissions should be made via the Wiley Authors submission portal. You may check the status of your submission at any time by logging on to authors.wiley.com and clicking the “My Submissions” button. For technical help with the submission system, please review our FAQs or contact submissionhelp@wiley.com. This journal does not charge submission fees. Article Preparation Support Wiley Editing …
Source ↗Publisher website ·- Preprints
Preprint policy: accepts previously published preprints and allows posting submitted version Model summary
This journal accepts articles previously published on preprint servers. You may also post the submitted version of a manuscript to a preprint server at any time.
Source ↗Publisher website ·- Self-archiving Embargo Policy
Once submitted, articles cannot be discussed with the media until one week before the publication date. Accepted articles are embargoed from reporting by all media until 12:01 A.M. (EST) on the date of online publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- John Wiley and Sons Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Semimonthly
- ISSN
- 0008-543X
- Electronic ISSN
- 1097-0142
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Cancer
What CAS zone is Cancer in?
In the 2025 upgraded edition of the CAS Journal Ranking, Cancer is in Zone 1 of Medicine, and in Zone 2 of the minor category Oncology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Cancer?
The latest impact factor listed by LetPub is 5.6; CiteScore 10.6, h-index 474.
How long does peer review take at Cancer?
Based on the dates recorded on 80 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 98 days (interquartile range 74–139 days); authors report an average review time of 2–3 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 8% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Cancer?
According to the journal's author guidelines: Abstract: ≤ 250 words; Reference style: AMA; First submission: Free format: the journal's layout is not required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Cancer based?
Of the 3 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Canada (1), Australia (1) and Lebanon (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Cancer?
According to LetPub and DOAJ records, Cancer is indexed in SCIE and Scopus. The journal's website also lists Web of Science, MEDLINE, PubMed, Embase, CAS, CAB Abstracts, CINAHL and Current Contents; that list has not been checked against each database.
Is Cancer open access, and what is the APC?
Cancer is a hybrid journal. For open-access publication: APC about USD 4,790.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .